National Quality Measures Clearinghouse | Radiation oncology: Australian Council on Healthcare Standards

Australian Council on Healthcare Standards


Radiation oncology: percentage of curative megavoltage radiotherapy courses provided, where CT planning was utilised, during the 6 month time period. This updates a previously published measure summary.
National Quality Measures Clearinghouse | Radiation oncology: percentage of curative megavoltage radiotherapy courses provided, where CT planning was utilised, during the 6 month time period.


Radiation oncology: percentage of patients receiving megavoltage radiotherapy using multi-leaf collimators (MLCs), during the 6 month time period. This updates a previously published measure summary.

National Quality Measures Clearinghouse | Radiation oncology: percentage of patients receiving megavoltage radiotherapy using multi-leaf collimators (MLCs), during the 6 month time period.

Radiation oncology: percentage of patients receiving radiotherapy, who have a letter on file to the referring doctor and general practitioner, regarding the current radiotherapy course, during 1 week in May or November. This updates a previously published measure summary.

National Quality Measures Clearinghouse | Radiation oncology: percentage of patients receiving radiotherapy, who have a letter on file to the referring doctor and general practitioner, regarding the current radiotherapy course, during 1 week in May or November.

Radiation oncology: percentage of patients waiting more than 14 days from the date 'ready for care', to the date of commencing radiotherapy, during 1 week in May or November. This updates a previously published measure summary.

National Quality Measures Clearinghouse | Radiation oncology: percentage of patients waiting more than 14 days from the date 'ready for care', to the date of commencing radiotherapy, during 1 week in May or November.

Radiation oncology: percentage of patients who had radiotherapy for breast conservation (pT1-3, any nodal staging, M0), during the 6 month time period, who had complete follow-up. This updates a previously published measure summary.
National Quality Measures Clearinghouse | Radiation oncology: percentage of patients who had radiotherapy for breast conservation (pT_1-3, any nodal staging, M0), during the 6 month time period, who had complete follow-up.


Radiation oncology: percentage of patients who had radiotherapy for glottic cancer (T1-2 N0 M0), during the 6 month time period, who had complete follow-up. This updates a previously published measure summary.
National Quality Measures Clearinghouse | Radiation oncology: percentage of patients who had radiotherapy for glottic cancer (T1-2 N0 M0), during the 6 month time period, who had complete follow-up.


Radiation oncology: percentage of patients who have informed consent recorded in the medical record before receiving radiotherapy, during 1 week in May or November. This updates a previously published measure summary.

National Quality Measures Clearinghouse | Radiation oncology: percentage of patients who have informed consent recorded in the medical record before receiving radiotherapy, during 1 week in May or November.

Radiation oncology: percentage of patients who receive curative chemoradiotherapy for squamous cell carcinoma (SCC) of the cervix in the definitive or the post-operative setting, during the 6 month time period. This updates a previously published measure summary.

National Quality Measures Clearinghouse | Radiation oncology: percentage of patients who receive curative chemoradiotherapy for squamous cell carcinoma (SCC) of the cervix in the definitive or the post-operative setting, during the 6 month time period.

Radiation oncology: percentage of patients with squamous cell carcinoma (SCC) of the oral cavity, oropharynx, hypopharynx and larynx who wait longer than 6 weeks from their definitive surgery to commencing their radiotherapy, during the 6 month time period. This updates a previously published measure summary.
National Quality Measures Clearinghouse Radiation oncology: percentage of patients with squamous cell carcinoma (SCC) of the oral cavity, oropharynx, hypopharynx and larynx who wait longer than 6 weeks from their definitive surgery to commencing their radiotherapy, during the 6 month time period.